Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

XLOXLO
2 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in XILIO THERAPEUTICS INC

JPMORGAN CHASE & CO previously held 0 shares of XLO (XILIO THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1,976

Total Shares Change

-240

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$9.58
0
2026-Q1
New
240
-
$1,9760.0%$8.41
17

Other major holders of XLO: VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used